LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 72 filers reported holding LOXO ONCOLOGY INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $5,288,000 | +27.8% | 37,751 | +55.8% | 0.01% | +50.0% |
| Q3 2018 | $4,139,000 | -7.0% | 24,227 | -5.6% | 0.01% | -11.1% |
| Q2 2018 | $4,450,000 | +80.5% | 25,651 | +20.1% | 0.01% | +80.0% |
| Q1 2018 | $2,465,000 | +32.7% | 21,365 | -3.2% | 0.01% | +25.0% |
| Q4 2017 | $1,858,000 | -20.1% | 22,073 | -12.5% | 0.00% | -20.0% |
| Q3 2017 | $2,325,000 | +28.2% | 25,234 | +11.5% | 0.01% | +25.0% |
| Q2 2017 | $1,814,000 | +148.2% | 22,626 | +30.3% | 0.00% | +100.0% |
| Q1 2017 | $731,000 | +59.6% | 17,366 | +21.9% | 0.00% | +100.0% |
| Q4 2016 | $458,000 | +39.2% | 14,248 | +13.3% | 0.00% | 0.0% |
| Q3 2016 | $329,000 | +21.4% | 12,574 | +7.5% | 0.00% | 0.0% |
| Q2 2016 | $271,000 | -21.7% | 11,699 | -7.6% | 0.00% | 0.0% |
| Q1 2016 | $346,000 | +16.1% | 12,657 | +20.9% | 0.00% | 0.0% |
| Q4 2015 | $298,000 | – | 10,472 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 2,038,920 | $285,592,000 | 80.87% |
| DAFNA Capital Management LLC | 181,675 | $25,447,000 | 12.65% |
| Opaleye Management Inc. | 175,000 | $24,512,000 | 9.15% |
| Casdin Capital, LLC | 360,000 | $50,425,000 | 8.63% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 21,775 | $3,050,000 | 3.58% |
| Avoro Capital Advisors LLC | 325,000 | $45,523,000 | 2.72% |
| AWM Investment Company, Inc. | 70,000 | $9,805,000 | 2.13% |
| Opus Point Partners Management, LLC | 6,210 | $870,000 | 1.92% |
| Eventide Asset Management | 274,000 | $38,379,000 | 1.70% |
| Aquilo Capital Management, LLC | 24,750 | $3,467,000 | 1.68% |